Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Combination of Toripalimab With Preoperative Chemoradiotherapy for Locally Advanced Adenocarcinoma of Esophagogastric Junction

NCT04061928 is registered in ClinicalTrials.gov with Peking University as lead sponsor.

NCT NCT04061928
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04061928 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Combination of Toripalimab With Preoperative Chemoradiotherapy for Locally Advanced Adenocarcinoma of Esophagogastric Junction
Lead sponsor
Peking University
Phase
Phase 1/2
Overall status
Unknown status
Start date
August 26, 2019
Completion date
August 25, 2023
Enrollment
45 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chemoradiotherapy, gastroesophageal junction cancer, pd-1